4//SEC Filing
Brzeczko Albert W 4
Accession 0001209191-17-065033
CIK 0000786947other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:14 PM ET
Size
6.3 KB
Accession
0001209191-17-065033
Insider Transaction Report
Form 4
Brzeczko Albert W
VP Technical Affairs
Transactions
- Award
Restricted Stock Units
2017-12-11+28,000→ 28,000 total→ Common Stock (28,000 underlying)
Footnotes (4)
- [F1]Awarded under the Acura Pharmaceuticals Inc. 2017 Restricted Stock Unit Award Plan (the "Plan").
- [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
- [F3]100% of Restricted Stock Units vest on December 11, 2018 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2020, 2021, and 2022 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
- [F4]N/A
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001455740
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:14 PM ET
- Size
- 6.3 KB